Slides from June fundraise
- Rorkes
- Jun 9, 2020
- 1 min read
Placing to raise working capital to fund scale-up of the COVID-19 antigen testing opportunity, and funding to accelerate expansion of in-house pipeline of Affimer immunotherapies and preCISION cancer therapies, and accelerate expansion of in-house diagnostic product pipeline.
Comments